Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Pain × Clear all

Phase

Phase NA 27 Phase 2 5 Phase 3 2 Phase 1 2 Phase 4 1

Status

Completed 36 Unknown 8 Terminated 7 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Prostatic Neoplasms 12 Neoplasms 12 Carcinoma, Hepatocellular 9 Multiple Myeloma 8 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Papillomavirus Infections 7 Lung Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Liver Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Kidney Neoplasms 4 Heart Failure 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Febrile Neutropenia 3

Interventions

Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05088876 2025-11-26

ParOP

Insel Gruppe AG, University Hospital Bern

Phase 4 Recruiting

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡